Rentiapril racemate

• CAT Number: I013465
• CAS Number: 72679-47-1
• Molecular Formula: C₁₃H₁₅NO₄S₂
• Molecular Weight: 313.39
• Purity: ≥95%
• Target: Angiotensin-converting Enzyme (ACE)
• Solubility: DMSO
• IUPAC Name: 2-(2-hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid
• InChI: InChI=1S/C13H15NO4S2/c15-10-4-2-1-3-8(10)12-14(11(16)5-6-19)9(7-20-12)13(17)18/h1-4,9,12,15,19H,5-7H2,(H,17,18)
• InChIKey: BSHDUMDXSRLRBI-UHFFFAOYSA-N
• SMILES: C1C(N(C(S1)C2=CC=CC=C2O)C(=O)CCS)C(=O)O

Rentiapril Racemate(CAT: I013465) is a racemic mixture of Rentiapril, a compound studied for its potential as an angiotensin-converting enzyme (ACE) inhibitor. It is of significant interest in cardiovascular research, particularly for exploring treatments for hypertension and heart failure. By inhibiting ACE, Rentiapril Racemate helps to modulate the renin-angiotensin-aldosterone system (RAAS), leading to vasodilation and reduced blood pressure. Its dual enantiomer composition allows researchers to investigate stereoselective pharmacokinetics and pharmacodynamics, offering valuable insights into enantiomer-specific activity. This compound is an essential tool for drug discovery and the development of novel therapeutic agents targeting cardiovascular diseases.